1.
Vincenzi B, Frezza AM, Silletta M, Dell’Aquila E, Catania G, Santini D, Tonini G. Aprepitant plus palonosetron as salvage therapy for CINV induced by moderately emetogenic chemotherapy in cancer patients:  . CBN [Internet]. 2016 Mar. 15 [cited 2024 Nov. 23];4(1):20-5. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/201